- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Apixaban 5MG
Total 12623 results
-
New York Medical CollegeCompletedVenous ThromboembolismUnited States
-
Thomas Jefferson UniversityCompletedPancreas Cancer | Pulmonary Embolism | DVTUnited States
-
Johns Hopkins UniversityCompletedObesity | Bariatric SurgeryUnited States
-
University of AlbertaCompletedIschemic Stroke | Atrial Fibrillation | Transient Ischemic AttackCanada
-
Jiangsu vcare pharmaceutical technology co., LTDCompletedCoronary Artery Disease | Percutaneous Coronary Intervention | Platelet Aggregation InhibitorsChina
-
Mitsubishi Tanabe Pharma CorporationCompletedSchizophreniaTaiwan, Korea, Republic of, Japan
-
AtriCure, Inc.CompletedAtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS) (ATLAS)Post-Operative Atrial FibrillationUnited States
-
Beijing Union Pharmaceutical Factory LtdR&G Pharma Studies Co.,Ltd.RecruitingGeneralized Anxiety DisorderChina
-
Nirmish ShahBristol-Myers SquibbTerminatedSickle Cell Disease | Vaso-occlusive Crisis | Reduction in HospitalizationsUnited States
-
Gregory PiazzaBristol-Myers SquibbCompletedMultiple Myeloma | Venous ThromboembolismUnited States
-
University Hospital, AkershusCompletedNeoplasms | Venous ThrombosisNorway
-
PfizerBristol-Myers SquibbTerminatedAcute Coronary SyndromeJapan
-
University of Vermont Medical CenterDartmouth-Hitchcock Medical Center; MaineHealthNot yet recruitingGlioblastoma | Astrocytoma | Venous Thromboembolism
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong KongRecruiting
-
Seoul National University HospitalActive, not recruitingAtrial FibrillationKorea, Republic of
-
Bristol-Myers SquibbCompleted
-
Institute for Clinical and Experimental MedicineRecruiting
-
PfizerCompletedNon-valvular Atrial FibrillationJapan
-
Brigham and Women's HospitalCompletedVenous ThromboembolismUnited States
-
Mayo ClinicBristol-Myers Squibb; PfizerTerminated
-
Technical University of MunichCompletedAnaesthesia | Respiratory Paralysis | Observation of Neuromuscular BlockGermany
-
Novartis PharmaceuticalsCompletedSchizophrenia DisordersUnited States
-
Khyber Medical University PeshawarCompleted
-
Kinarus AGSuspended
-
Institut de Recherches Internationales ServierADIR AssociationCompletedMajor Depressive DisorderBulgaria, Czechia, Finland, Hungary, Russian Federation, Slovakia, Ukraine
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Indiana UniversityEli Lilly and CompanyTerminated
-
Vastra Gotaland RegionGöteborg UniversityRecruitingTakotsubo SyndromeNorway, Denmark, Sweden
-
Serpin Pharma, LLCUniversity of VirginiaTerminated
-
Kaohsiung Medical UniversityRecruiting
-
BayerJanssen, LPCompletedAtrial FibrillationUnited Kingdom
-
Novartis PharmaceuticalsWithdrawnAtrial Fibrillation
-
Mayo ClinicBristol-Myers SquibbWithdrawnPatent Foramen Ovale | Cardiac Implantable Electronic DeviceUnited States
-
Bristol-Myers SquibbCompletedDeep Vein Thrombosis | Pulmonary EmbolismMexico
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedAcute Coronary Syndrome (ACS)Canada, Italy, Poland, Sweden, United States, Spain, Austria, Denmark, France, Belgium, Israel, Germany, Russian Federation, United Kingdom
-
Michael KovacsOttawa Hospital Research Institute; Jewish General HospitalRecruitingCancer Patients | Central Venous Catheter Thrombosis | Upper Extremity ThrombosisCanada
-
EnnovaBio Australia Pharmaceuticals Pty LtdCompleted
-
GlaxoSmithKlineCompletedChronic Idiopathic Thrombocytopenic Purpura | Purpura, Thrombocytopenic, IdiopathicJapan
-
Stanford UniversityWithdrawnDepression | Major Depressive Disorder
-
Regeneron PharmaceuticalsActive, not recruitingVenous ThromboembolismPoland, Latvia, Canada, Belgium, Bulgaria, Hungary, Lithuania
-
Portola PharmaceuticalsCompleted
-
Montefiore Medical CenterCompletedAnalgesia After ED Discharge for Extremity InjuriesUnited States
-
Vigonvita Life SciencesCompletedErectile DysfunctionChina
-
Chong-Jin KimHanmi Pharmaceutical Company LimitedCompleted
-
Bristol-Myers SquibbPfizerCompletedNonValvular Atrial FibrillationJapan